The invention provides compounds for use in a method of treating oralpharyngeal dysphagia in an individual andrelated products. One embodiment of the invention comprises administering toan individual an effective amount of a vanilloidreceptor 1 (VR-1) agonist or high-affinity partial agonist to promote aswallow reflex.